SCHEMBL25855295

SCHEMBL25855295

C=C(C)C(=O)OC1CCC(Oc2ccc3cc(-c4ccc(CCCCC)cc4C(F)(F)F)c(=O)oc3c2)C1(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 1/20 0.34
TERT O14746 3/20 0.34
MAOB P27338 3/20 0.33
MAOA P21397 2/20 0.33
NPC1 O15118 4/20 0.32
RAB9A P51151 4/20 0.32
KDM4E B2RXH2 3/20 0.32
HPGD P15428 2/20 0.32
MEN1 O00255 1/20 0.31
GLA P06280 1/20 0.31
KMT2A Q03164 1/20 0.31
PTPN7 P35236 1/20 0.31
S1PR1 P21453 1/20 0.31
S1PR3 Q99500 1/20 0.31
ACHE P22303 1/20 0.31
BACE1 P56817 1/20 0.31
HSD11B1 P28845 1/20 0.31
FPR1 P21462 2/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22625063 0.93 TERT (0.34) STSTERTMAOBMAOANPC1
SCHEMBL25848281 0.91 NPC1 (0.35) STSMAOBMAOANPC1RAB9A
SCHEMBL25848290 0.90 STS (0.33) STSTERTMAOBMAOANPC1
SCHEMBL25848285 0.90 MAOB (0.36) MAOBMAOANPC1RAB9AKDM4E
SCHEMBL25848292 0.89 KDM4E (0.38) MAOBMAOANPC1RAB9AKDM4E
SCHEMBL22625122 0.86 STS (0.34) STSTERTMAOBMAOANPC1
SCHEMBL22624937 0.86 MAOB (0.33) TERTMAOBMAOANPC1RAB9A
SCHEMBL22625059 0.85 KDM4E (0.36) MAOBMAOANPC1RAB9AKDM4E
SCHEMBL21735059 0.84 S1PR1 (0.36) S1PR1S1PR3
SCHEMBL22625305 0.84 STS (0.33) STSTERTMAOBMAOANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 STS 4081/4885TERT 1163/4885MAOB 3207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.